VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 178 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $306,722 | -45.8% | 71,000 | -14.8% | 0.00% | – |
Q2 2023 | $565,669 | 0.0% | 83,309 | 0.0% | 0.00% | – |
Q1 2023 | $565,669 | +27.3% | 83,309 | +38.5% | 0.00% | – |
Q4 2022 | $444,509 | -99.9% | 60,150 | 0.0% | 0.00% | – |
Q3 2022 | $594,280,000 | -9.4% | 60,150 | 0.0% | 0.00% | – |
Q2 2022 | $655,635,000 | -3.6% | 60,150 | 0.0% | 0.00% | – |
Q1 2022 | $680,295,000 | -27.9% | 60,150 | 0.0% | 0.00% | – |
Q4 2021 | $943,755,000 | -8.5% | 60,150 | 0.0% | 0.00% | – |
Q3 2021 | $1,030,970,000 | +0.2% | 60,150 | +25.7% | 0.00% | – |
Q2 2021 | $1,029,060,000 | +66.1% | 47,841 | +16.0% | 0.00% | – |
Q1 2021 | $619,709,000 | -1.4% | 41,259 | -13.8% | 0.00% | – |
Q4 2020 | $628,750,000 | +36.0% | 47,850 | 0.0% | 0.00% | – |
Q3 2020 | $462,232,000 | -15.6% | 47,850 | 0.0% | 0.00% | – |
Q2 2020 | $547,404,000 | +17.3% | 47,850 | +6.2% | 0.00% | – |
Q1 2020 | $466,573,000 | -28.5% | 45,036 | +13.3% | 0.00% | – |
Q4 2019 | $652,183,000 | +10.0% | 39,743 | -11.0% | 0.00% | – |
Q3 2019 | $593,033,000 | +22.6% | 44,656 | +30.1% | 0.00% | – |
Q2 2019 | $483,667,000 | +44.8% | 34,327 | +89.1% | 0.00% | – |
Q1 2019 | $334,070,000 | -4.8% | 18,156 | +35.3% | 0.00% | – |
Q4 2018 | $350,769,000 | +129335.1% | 13,424 | -17.6% | 0.00% | – |
Q3 2016 | $271,000 | +48.9% | 16,300 | 0.0% | 0.00% | – |
Q2 2016 | $182,000 | +48.0% | 16,300 | +10.9% | 0.00% | – |
Q1 2016 | $123,000 | -56.5% | 14,700 | -51.6% | 0.00% | – |
Q4 2015 | $283,000 | -20.9% | 30,400 | -4.4% | 0.00% | – |
Q3 2015 | $358,000 | -5.5% | 31,800 | +6.4% | 0.00% | – |
Q2 2015 | $379,000 | +43.0% | 29,900 | +4.9% | 0.00% | – |
Q1 2015 | $265,000 | -32.7% | 28,500 | +3.6% | 0.00% | – |
Q4 2014 | $394,000 | +217.7% | 27,500 | +131.1% | 0.00% | – |
Q3 2014 | $124,000 | -35.8% | 11,900 | 0.0% | 0.00% | – |
Q2 2014 | $193,000 | – | 11,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |